ABSTRACT
An abortion outbreak occurred in a goat herd of Murciano-Granadina breed in Almeria Region in Spain where 80 pregnant females aborted. All bacteriological and parasitological examinations resulted negative, whereas virological investigations and real-time PCR assay showed the presence of Caprine alphaherpesvirus 1 DNA in the pathological specimens from aborted foetuses. Nucleotide sequence analysis revealed that the DNA was highly close related to the Swiss strain E-CH (99.7%) and a little less extent to the Italian BA.1 strain (99.4%). Histopathological examination revealed multifocal, well-circumscribed, 50- to 200-µm-diameter foci of coagulative necrosis in the liver, lungs and kidneys of three foetuses. In the periphery of the necrosis, there were frequently epithelial cells with the chromatin emarginated by large, round, amphophilic intranuclear viral inclusion bodies. The source of the infection in the herd could not clearly find out even some hypothesis were formulated. This seems to be the first report of an abortion outbreak due to Caprine alphaherpesvirus 1 in a goat herd in Spain.
Subject(s)
Abortion, Veterinary/virology , Goat Diseases/virology , Herpesviridae Infections/veterinary , Varicellovirus/isolation & purification , Aborted Fetus/pathology , Aborted Fetus/virology , Abortion, Veterinary/epidemiology , Animals , DNA, Viral , Disease Outbreaks/veterinary , Female , Goat Diseases/pathology , Goats , Herpesviridae Infections/pathology , Herpesviridae Infections/virology , Pregnancy , Spain/epidemiology , Varicellovirus/geneticsABSTRACT
Vector-borne pathogens have been increasingly investigated for their impact on dog and cat health and their zoonotic potential. The aim of this study was to investigate the prevalence estimates of selected vector-borne pathogens in client-owned pets from the Giza and Cairo governorates, Egypt. Out of 200 dogs and 100 cats, 94 (47%) and 23 (23%) were positive for at least one of the tested pathogens (P<0.0001). In particular, 84 (42%) dogs and 3 (3%) cats tested PCR-positive for Bartonella spp. (P<0.0001). A significantly higher prevalence of Bartonella spp. was detected in dogs from the rural areas of the Giza governorate (60/77, 79.2%, P<0.0001) compared to those from Cairo governorate. Bartonella henselae was the dominant species infecting dogs (81/200, 40.5%) followed by Candidatus Bartonella merieuxii (3/200, 1.5%), while B. henselae (2/100, 2%) and B. clarridgeiae were rare in cats. Haemoplasma DNA was detected in 17% (34/200) of dogs and 20% (20/100) of cats with increased risk in dogs from Giza rural areas (21/77, 27.27%, P=0.002) and from both dogs (16/63, 25.40%, P=0.03) and cats (7/14, 50%, P<0.002) with anemia. Candidatus Mycoplasma haematoparvum (30/200, 15%) and Mycoplasma haemocanis (4/200, 2%) in dogs and Candidatus Mycoplasma haemominutum (18/100, 18%) and M. haemofelis (2/100, 2%) in cats were detected. Additionally, 2 dogs were positive for C. burnetii DNA. Coinfections were detected in dogs, with the majority (23/200, 11.5%) including B. henselae and C.M. haematoparvum, followed by Mycoplasma haemocanis and C.M. haematoparvum (2/200, 1%) and B. henselae, CMhp and C. burnetii (2/200, 1%). Haemoplasma infection was high in Egyptian dogs and cats with a high prevalence for zoonotic Bartonella spp. in dogs with anemia, highlighting the need to investigate these agents in the diagnostic algorithm of anemia and to adopt preventive measures to protect both animal and human health.
Subject(s)
Anemia , Bartonella , Cat Diseases , Dog Diseases , Mycoplasma , Humans , Animals , Cats , Dogs , Cat Diseases/epidemiology , Egypt , Prevalence , Dog Diseases/epidemiology , Mycoplasma/geneticsABSTRACT
Breast cancer represents the most prevalent malignancies in women and bone is the first site of metastasis in 26-50% of cases. Usually metastasis involve limbs in 16%. We present a rare case of 47-year-old woman, who underwent to monolateral mastectomy for lobular cancer. After 8 years from surgery, she presented pain, swelling and functional limitations, gradually increasing, to the left big toe. X-rays and MRI showed a lucent area of bone destruction on the shaft of the distal phalanx of the left big toe. Surgical biopsy on the excised bone assessed for breast cancer metastasis.
Subject(s)
Bone Neoplasms/secondary , Breast Neoplasms/pathology , Carcinoma, Lobular/secondary , Estrogens , Neoplasms, Hormone-Dependent/secondary , Toe Phalanges/pathology , Antineoplastic Agents, Hormonal/therapeutic use , Bone Neoplasms/diagnosis , Breast Neoplasms/drug therapy , Breast Neoplasms/surgery , Carcinoma, Lobular/diagnosis , Carcinoma, Lobular/drug therapy , Carcinoma, Lobular/surgery , Chemotherapy, Adjuvant , Combined Modality Therapy , Diagnostic Errors , Female , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/secondary , Mastectomy, Radical , Middle Aged , Neoplasms, Hormone-Dependent/diagnosis , Neoplasms, Hormone-Dependent/drug therapy , Neoplasms, Hormone-Dependent/surgery , Osteomyelitis/diagnosis , Radiography , Tamoxifen/therapeutic use , Toe Phalanges/surgeryABSTRACT
Latent infection is a common mechanism used by several alphaherpesviruses to persist in their host but it is not clear whether this mechanism is also triggered in heterologous infections. Cross-species infections have been documented repeatedly for alphaherpesviruses of ruminants, a group of closely related viruses. Herewith we report latent infection with bubaline alphaherpesvirus 1 (BuHV-1) in experimentally infected goats and subsequent virus reactivation after treatment with dexamethasone (DMS) at 10 months after infection. After DMS treatment, the virus was isolated in one such animal in the nasal swabs from day 3 to 9 post treatment and in the ocular swabs at day 6. The goat was euthanized 48 days after DMS treatment and viral DNA was detected by PCR in the trigeminal ganglia and in two cervical ganglia. Additionally, BuHV-1 DNA was detected by PCR in the trigeminal ganglia of the other 3 goats.
Subject(s)
Alphaherpesvirinae/physiology , Animal Diseases/virology , Herpesviridae Infections/veterinary , Virus Activation , Virus Latency , Alphaherpesvirinae/classification , Animal Diseases/immunology , Animals , Cell Line , Goats , Neutralization Tests , Viral LoadABSTRACT
Coxiella burnetii causes diseases in humans (Q fever) and animals, domestic ruminants playing a major role in the epidemiology of the infection. Information on C. burnetii infection in Lebanon is scanty. In order to assess the prevalence of C. burnetii infection in ruminants, a cross-sectional study was undertaken in 2014. A total of 1633 sera from ruminants (865 cattle, 384 sheep and 384 goats) from 429 farms (173 cattle, 128 sheep and 128 goats), in seven provinces of Lebanon were randomly selected and assayed for the presence of antibodies. 39.86% of farms (95% CI: 35.23-44.56) resulted positive. The seroprevalence was 30.63% in Cattle-farms, 46.88% in sheep-farms and 45.31% in goat-farms. Milk samples collected from 282 seropositive animals (86 cows, 93 sheep and 103 goats) from 171 positive farms were tested by a high sensitive Real-Time PCR targeted to the IS1111 transposon of C. burnetii. The overall prevalence in farms was estimated to be 14.04%. Cattle-, sheep- and goat farm prevalence rates were 15.09%, 10% and 17.24%, respectively. The findings of the study show that C. burnetii prevalence in Lebanese domestic ruminants is related to animal species and farming practices. Indeed, the mixed herds with sheep (p < 0.01), the presence of common lambing/kidding areas (p < 0.001) in farms where the use of disinfectants was not a routine practice (p < 0.05) were identified as important risk factors. The results of the study provide baseline information for setting up herd management and public health measures for the prevention and control of Q fever in Lebanon.
Subject(s)
Antibodies, Bacterial/blood , Coxiella burnetii/isolation & purification , Milk/microbiology , Q Fever/veterinary , Ruminants/microbiology , Animals , Bacterial Proteins/genetics , Cattle , Cattle Diseases/epidemiology , Coxiella burnetii/genetics , Cross-Sectional Studies , Farms , Goat Diseases/epidemiology , Goats , Lebanon/epidemiology , Prevalence , Q Fever/epidemiology , Real-Time Polymerase Chain Reaction , Risk Factors , Seroepidemiologic Studies , Sheep , Sheep Diseases/epidemiologyABSTRACT
Caprine herpesvirus 1 (CpHV-1) infection in goats induces genital vesicular-ulcerative lesions that strictly resemble those produced by human herpesvirus 2 in humans. In previous studies, the potent inhibition of CpHV-1 by cidofovir was demonstrated. Cidofovir antiherpetic activity was evaluated in goats infected experimentally by the vaginal route with CpHV-1 and then treated locally at different times after infection. The administration of 1% cidofovir cream onto vaginal mucosa was able to prevent the onset of genital lesions and to decrease significantly the titers of the virus shed by the infected animals, notably in the groups treated shortly after infection (24 and 48 h). The efficacy of cidofovir against caprine herpesvirus infection was higher when the treatment was started shortly after infection than when lesions were already present and advanced. Herpesvirus genital infection of goats is a useful animal model to study the activity of antiviral drugs against human herpesvirus infections.
Subject(s)
Antiviral Agents/therapeutic use , Cytosine/analogs & derivatives , Genital Diseases, Female/veterinary , Goat Diseases/drug therapy , Herpesviridae Infections/veterinary , Organophosphonates/therapeutic use , Varicellovirus , Animals , Antiviral Agents/administration & dosage , Base Sequence , Cidofovir , Cytosine/administration & dosage , Cytosine/therapeutic use , DNA Primers/genetics , DNA, Viral/genetics , Disease Models, Animal , Female , Genital Diseases, Female/drug therapy , Goat Diseases/virology , Goats , Herpes Genitalis/drug therapy , Herpesviridae Infections/drug therapy , Herpesviridae Infections/virology , Humans , Organophosphonates/administration & dosage , Species Specificity , Vaginal Creams, Foams, and Jellies , Varicellovirus/drug effects , Varicellovirus/genetics , Varicellovirus/isolation & purificationABSTRACT
Nowadays, the treatment of the difficult wounds represents an emergent socio-sanitary problem, due to the increase of the average duration of life, with consequent increasing costs by the National Sanitary System. The term 'difficult wounds' refers to all losses of cutaneous substances with multifactorial pathogenesis that do not spontaneously recover. Today it is possible to use advanced dressings, representing a valid tool to speed-up the healing process that--as a consequence--improves quality of life for the patient. These patients need to be followed by medical teams composed by different specialists sometimes working in different hospitals. As a consequence it is has been necessary to create an electronic document containing the clinical history of the patient and reporting the different treatments. The electronic sheet allows: a) to evaluate in detail the evolution of patient conditions, thanks to an always available iconographic documentation, even when the patient is not followed by the same physician; b) and to test the effectiveness of the new advanced dressings available on the market.
Subject(s)
Bandages , Medical Records Systems, Computerized , Patient Care Team , Skin Ulcer/therapy , Wound Healing , Adult , Aged , Female , Humans , Male , Middle Aged , Quality of LifeABSTRACT
Herpesvirus infections are generally subjected to strong host species restriction, although virological and serological investigations have revealed the possibility of cross-species infections in closely related animal species. In this study we evaluated susceptibility of goats to infection by Bubaline alphaherpesvirus 1 (BuHV-1). Four goats were inoculated intra-nasally with BuHV-1 and monitored clinically, virologically and serologically for 42days. None of the goats displayed clinical signs although all the animals variably shed the virus by the nasal route during the first 12days after infection. BuHV-1 was also detected in the white blood cells of two animals in the first week post infection. The results suggest that goats are susceptible to BuHV-1 infection and that they could play an epidemiological role in the circulation/transmission of the virus among domestic and wild ruminants and impact to some extent on the control plans for herpesviruses in cattle.
Subject(s)
Goat Diseases/virology , Goats/virology , Herpesviridae Infections/veterinary , Herpesvirus 1, Bovine/physiology , Animals , Antibodies, Viral/blood , Asymptomatic Infections/epidemiology , Disease Susceptibility/veterinary , Female , Goat Diseases/epidemiology , Goat Diseases/transmission , Herpesviridae Infections/epidemiology , Herpesviridae Infections/transmission , Herpesviridae Infections/virology , Herpesvirus 1, Bovine/immunology , Italy/epidemiology , Leukocytes/virology , Male , Nose/virology , Polymerase Chain Reaction , Virus Latency , Virus SheddingABSTRACT
The metabolism of cholesterol sulfate (CS) was investigated in immortalized, Epstein-Barr virus-transformed lymphoid cell lines derived from normal individuals and patients affected with recessive X-linked ichthyosis (XLI). Normal lymphoid cells expressed arylsulfatase C and steroid sulfatase (including cholesterol sulfatase) activities, and these two sulfohydrolases showed the same enzyme properties as in other human cells, e.g., leukocytes or skin fibroblasts. XLI-derived lymphoid cell lines exhibited extremely deficient activity of both arylsulfatase C and steroid sulfatase. While normal and XLI intact, living lymphoid cells could take up exogenous radiolabelled CS through a non-receptor-mediated process. XLI cells were completely unable to degrade CS to cholesterol. However, despite their defect in CS degradation, steroid sulfatase-deficient cells did not accumulate CS because of outflux of this sterol. The potential implications of these findings to the pathogenesis of increased CS content in plasma and epidermis of XLI patients are discussed. This study also demonstrates that immortalized lymphoid cell lines may represent a useful experimental model system for the study of XLI.
Subject(s)
Cholesterol Esters/metabolism , Ichthyosis, X-Linked/metabolism , Leukocytes/metabolism , Adolescent , Arylsulfatases/analysis , Cell Line, Transformed , Child , Child, Preschool , Fibroblasts/enzymology , Fibroblasts/metabolism , Herpesvirus 4, Human , Humans , Hydrogen-Ion Concentration , Ichthyosis, X-Linked/enzymology , Leukocytes/enzymology , Steryl-SulfataseABSTRACT
The effects of low-dose lead occupational exposure on neurobehavioral functions are still not well defined by international literature. The objective of this study is to assess by psychometric testing the presence of possible neuropsychological impairment in a group of male Italian workers with low blood lead levels in comparison to an adequate non exposed worker group. Given informed consent to take part to the study, all workers were interviewed about their working and clinical history and underwent determination of blood lead levels (PbB). An internationally validated computerized battery of psychometric tests and a standardized paper-and-pencil version of mood self-rating scale and WAIS-R Vocabulary subtest were also administered to the workers. Exposed workers had a geometric mean of PbB significantly higher than non exposed workers, but rather low (16.4 +/- 1.7 microg/dl). The results of psychometric tests were not significantly different between the two worker groups, even after adjusting for the main confounding factors. In workers exposed to low lead doses no neurobehavioral abnormalities were demonstrated by the administered psychometric test battery.
Subject(s)
Behavior/drug effects , Lead/pharmacology , Nervous System/drug effects , Occupational Exposure/adverse effects , Adult , Humans , Lead/blood , Male , Middle Aged , Psychological TestsABSTRACT
Caprine herpesvirus 1 (CpHV-1) infection in goats induces genital vesicular-ulcerative lesions that strictly resemble the lesions induced by herpesvirus 2 in the human host. The immunosuppressive drug Mizoribine (MIZ) was found to increase the antiviral activity of Acyclovir (ACV) against herpesvirus infections, raising interesting perspectives on new combined therapeutic strategies. In this study the anti-CpHV-1 activity in vitro of ACV alone or in combination with MIZ was characterized. When applied alone at non-toxic concentrations, ACV had a slight effect on CpHV-1 replication while in combination with MIZ a dose-dependent inhibition of the virus yield was observed with an IC50 of ACV of 28.5 µM. These findings suggest that combined therapy of ACV and MIZ is potentially exploitable in the treatment of genital infection by herpesviruses.
Subject(s)
Acyclovir/pharmacology , Antiviral Agents/pharmacology , Herpesviridae Infections/veterinary , Ribonucleosides/pharmacology , Varicellovirus/drug effects , Virus Replication/drug effects , Acyclovir/therapeutic use , Animals , Antiviral Agents/therapeutic use , Cattle , Cells, Cultured , Herpesviridae Infections/drug therapy , Herpesviridae Infections/virology , Ribonucleosides/therapeutic use , Varicellovirus/growth & developmentABSTRACT
The time course of degradation of a radiolabelled natural ceramide has been studied in intact, living lymphoid cells and skin fibroblasts from normal individuals and from patients affected with Farber disease, an inborn disorder of ceramide metabolism due to deficient activity of lysosomal ceramidase. The hydrolysis of ceramide in lysosomes was selectively followed by examining the turnover of an LDL-associated radioactive sphingomyelin. This permitted to estimate accurately the effective lysosomal ceramidase activity and to demonstrate: (i) a very active catabolism of ceramide in normal cells; and (ii) the absence of a complete block of ceramide degradation in Farber cells. The possible implication of ceramide as a lipid mediator of the pathogenesis of Farber disease is discussed.
Subject(s)
Ceramides/metabolism , Lipid Metabolism, Inborn Errors/metabolism , Amidohydrolases/metabolism , Cell Line , Cells, Cultured , Ceramidases , Humans , Lipoproteins, LDL/metabolism , Lysosomes/enzymology , Sphingomyelins/metabolismABSTRACT
The sequence of the VP7 gene of two rotaviruses isolated from dogs in southern Italy was determined and the inferred amino acid sequence was compared with that of other rotavirus strains. There was very high nucleotide and amino acid identity between canine strain RV198/95 and other canine strains, and to the human strain HCR3A. Strain RV52/96, however, was found to have about 95% identity to the G3 serotype canine strains K9, A79-10 and CU-1 and 96% identity to strain RV198/95 and to the simian strain RRV. Therefore both of the canine strains belong to the G3 serotype. Nevertheless, detailed analysis of the VP7 variable regions revealed that RV52/96 possesses amino acid substitutions uncommon to the other canine isolates. In addition, strain RV52/96 exhibited a nucleotide divergence greater than 16% from all the other canine strains studied; however, it revealed the closest identity (90.4%) to the simian strain RRV. With only a few exceptions, phylogenetic analysis allowed clear differentiation of the G3 rotaviruses on the basis of the species of origin. The nucleotide and amino acid variations observed in strain RV52/96 could account for the existence of a canine rotavirus G3 sub-type.
Subject(s)
Capsid Proteins , Capsid/genetics , Dog Diseases/virology , Rotavirus Infections/veterinary , Rotavirus/genetics , Amino Acid Sequence , Animals , Antigens, Viral/genetics , Cell Line , DNA, Viral , Dogs , Haplorhini , Humans , Italy , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction/methods , Rotavirus/classification , Rotavirus/isolation & purification , Rotavirus Infections/virology , Sequence Alignment , Sequence Analysis, DNA , SerotypingABSTRACT
28 isolates of canine parvovirus type-2 (CPV-2) were obtained from dogs with hemorrhagic gastroenteritis in Italy. The antigenic structure of CPV-2 isolates was characterized, using four discriminating monoclonal antibodies. In addition, four vaccinal strains were examined. Similar to reports from Australia and the United Kingdom, a much higher prevalence of CPV-2a (25/28 isolates) was observed than the other variant type, CPV-2b (3/28 isolates). DNA fragments (2.2 kbp) of representative strains of CPV-2, CPV-2a and CPV-2b were amplified by the polymerase chain reaction (PCR) and the products were digested by the restriction enzymes (RE) RsaI, HpaII, HindIII and PvuII. The RvaI enzyme allows the differentiation of CPV-2 from CPV-2a and CPV-2b.
Subject(s)
Antigens, Viral/immunology , Parvoviridae Infections/veterinary , Parvovirus, Canine/immunology , Animals , Antibodies, Monoclonal , Antigenic Variation , Capsid/genetics , Dogs , Feces/virology , Gastroenteritis/veterinary , Gastroenteritis/virology , Italy , Parvovirus, Canine/isolation & purification , Polymerase Chain Reaction , Restriction Mapping , Viral VaccinesABSTRACT
A diagnostic test for canine coronavirus (CCV) infection based on a nested polymerase chain reaction (n-PCR) assay was developed and tested using the following coronavirus strains: CCV (USDA strain), CCV (45/93, field strain), feline infectious peritonitis virus (FIPV, field strain), transmissible gastroenteritis virus (TGEV, Purdue strain), bovine coronavirus (BCV, 9WBL-77 strain), infectious bronchitis virus (IBV, M-41 strain) and fecal samples of dogs with CCV enteritis. A 230-bp segment of the gene encoding for transmembrane protein M of CCV is the target sequence of the primer. The test described in the present study was able to amplify both CCV and TGEV strains and also gave positive results on fecal samples from CCV infected dogs. n-PCR has a sensitivity as high as isolation on cell cultures, and can therefore be used for the diagnosis of CCV infection in dogs.
Subject(s)
Coronavirus Infections/veterinary , Coronavirus, Canine/isolation & purification , Dog Diseases/diagnosis , Polymerase Chain Reaction/methods , Animals , Cats , Cattle , Coronavirus Infections/diagnosis , Coronavirus Infections/virology , Diarrhea/diagnosis , Diarrhea/virology , Dog Diseases/virology , DogsABSTRACT
The results of polymerase chain reaction (PCR) and nested polymerase chain reaction (n-PCR) assays for the diagnosis of canine coronavirus (CCV) infection, and the comparison with other diagnostic techniques, such as electron microscopy (EM) and virus isolation using A-72 cell line are reported. The study was carried out on 71 faecal samples of pups with enteritis. Of 71 samples examined 14 were positive in PCR, whereas 30 samples resulted positive in the n-PCR assay. CCV was detected by EM examination in only four out of 45 samples, and by virus isolation in three out of 30 samples n-PCR positive.
Subject(s)
Coronavirus Infections/veterinary , Coronavirus, Canine/genetics , Coronavirus, Canine/isolation & purification , Dog Diseases/diagnosis , Dog Diseases/virology , Polymerase Chain Reaction/methods , Virology/methods , Animals , Base Sequence , Coronavirus Infections/diagnosis , Coronavirus Infections/virology , Coronavirus, Canine/ultrastructure , DNA Primers/genetics , Dogs , Feces/virology , Gastroenteritis/diagnosis , Gastroenteritis/veterinary , Gastroenteritis/virology , Microscopy, Electron , Polymerase Chain Reaction/statistics & numerical data , Sensitivity and Specificity , Virology/statistics & numerical dataABSTRACT
A nested polymerase chain reaction was used to identify 13 pestivirus strains isolated from small ruminants in several mixed (sheep and goats) flocks of Southern Italy, and for classification as bovine viral diarrhoea virus (BVDV) type 1, BVDV type 2, and Border disease virus (BDV) genotypes. Of the nine ovine isolates, two were characterized as BVDV type 1, and seven as BVDV type 2. The four pestiviruses isolated from kids belong to BVDV type 1. None of the pestivirus strains tested could be classified as 'true' BDV (genotype 3). Although BVDV type 2 has been described in Europe rarely, the characterization of BD/90-1M strain as BVDV type 2, isolated in Italy in 1990, demonstrates that this genotype has been circulating in Italy since the 1990s.
Subject(s)
Border disease virus/genetics , Diarrhea Virus 1, Bovine Viral/genetics , Diarrhea Virus 2, Bovine Viral/genetics , Genome, Viral , Animals , Border Disease/virology , Border disease virus/classification , Border disease virus/isolation & purification , Bovine Virus Diarrhea-Mucosal Disease/virology , Cattle , Diarrhea Virus 1, Bovine Viral/classification , Diarrhea Virus 1, Bovine Viral/isolation & purification , Diarrhea Virus 2, Bovine Viral/classification , Diarrhea Virus 2, Bovine Viral/isolation & purification , Goats , Italy , Pestivirus/classification , Pestivirus/genetics , Pestivirus/isolation & purification , SheepABSTRACT
Two strains of canine rotavirus were isolated from pups with clinical signs of gastroenteritis. Both strains were identified by polymerase chain reaction (PCR) as G3P5A[3], although restriction endonuclease analysis of the PCR amplicons revealed a genetic difference between the two isolates in the VP7 gene. The isolation in Italy of canine rotaviruses displaying the same VP7 and VP4 specificities as in the USA and in Japan, suggests that the G3 and P5A[3] types are highly conserved among canine rotavirus strains.
Subject(s)
Antigens, Viral , Capsid Proteins , Dog Diseases/virology , Gastroenteritis/veterinary , Polymerase Chain Reaction/methods , Rotavirus Infections/veterinary , Rotavirus/classification , Rotavirus/isolation & purification , Animals , Capsid/genetics , Dogs , Gastroenteritis/virology , Italy , Microscopy, Electron , Polymorphism, Restriction Fragment Length , Rotavirus/genetics , Rotavirus Infections/virologyABSTRACT
The enzyme activity of arylsulfatase A and arylsulfatase B was studied in Epstein-Barr virus-transformed lymphoid cell lines established from control individuals and patients affected with metachromatic leukodystrophy, mucopolysaccharidosis type VI (or Maroteaux-Lamy syndrome) and multiple sulfatase deficiency. Lymphoid cells derived from patients with metachromatic leukodystrophy showed a severe deficiency in cerebroside sulfatase activity, as measured using radiolabelled sulfatide, but some residual activity of arylsulfatase A when measured with the chromogenic substrate, para-nitrocatechol sulfate. Lymphoid cells from mucopolysaccharidosis type VI had virtually no arylsulfatase B activity. In cells from patients with multiple sulfatase deficiency, the activities of lysosomal sulfatases as well as steroid sulfatase were deficient. Study of the molecular forms of arylsulfatases confirmed the complete deficiency of arylsulfatase A and arylsulfatase B activities in metachromatic leukodystrophy and mucopolysaccharidosis type VI lymphoid cells, respectively. The arylsulfatase A defect in metachromatic leukodys-lymphoid cells, respectively. The arylsulfatase A defect in metachromatic leukodystrophy cells could be demonstrated on focused fractions even using the artificial substrates, para-nitrocatechol sulfate and 4-methylumbelliferyl sulfate. To investigate the discrepancy of the arylsulfatase A activity data observed between whole cell homogenates and focused fractions when using the synthetic substrates, assays were tentatively performed for optimizing the determination of arylsulfatase A on crude homogenates of lymphoid cells. Although this work has indicated methodological limitations of the enzymatic assay of arylsulfatase A in lymphoid cells using methylumbelliferyl sulfate, it emphasizes the validity of lymphoid cell lines as an experimental model for the study of inborn deficiencies of arylsulfatases A and B.
Subject(s)
B-Lymphocytes/enzymology , Cerebroside-Sulfatase/metabolism , Chondro-4-Sulfatase/metabolism , Herpesvirus 4, Human/genetics , Leukodystrophy, Metachromatic/enzymology , Mucopolysaccharidosis VI/enzymology , Sulfatases/deficiency , Cell Line, Transformed , Cerebroside-Sulfatase/isolation & purification , Chondro-4-Sulfatase/isolation & purification , Kinetics , Reference Values , ThermodynamicsABSTRACT
The safety and the efficacy of a modified-live (ML) canine coronavirus (CCoV) vaccine strain 257/98-3c was evaluated in 14 dogs seronegative and virus negative for CCoV. For the safety test, four dogs were inoculated, two by intramuscular and two by oronasal route, with 10 times the vaccinal dose. During the observation period (28 days) all dogs did not display any local or systemic reaction. For the efficacy test, eight dogs were vaccinated by intramuscular (four dogs-group A) or by oronasal route (four dogs-group B). Two dogs were maintained as non-vaccinated controls. In the dogs of group A, vaccinal virus was not detected in faecal samples by virus isolation (VI) and by PCR assay, while in the dogs of group B, the virus was revealed for six median days only by PCR. Twenty-eight days later, the vaccinated and control dogs were challenged with a field CCoV strain. After the challenge, the vaccinated dogs did not display clinical signs and the dogs of group A shed virus for 5.5 median days, evaluated by VI, and for 10 median days evaluated by PCR. Virus shedding was not observed, both by VI and PCR assay, in the dogs of group B. The two control dogs displayed moderate clinical signs and the virus was detected by VI for 14.5 median days starting from day 3 post-challenge (dpc 3) and by PCR assay for 23 median days starting from dpc 1.